Hochschulschrift
In-vivo-antisense-Targeting von Vasopressin mRNA in Ratten : = In vivo antisense targeting on vasopressin mRNA in rats
- Alternative title
-
In vivo antisense targeting on vasopressin mRNA in rats
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
VI, 63 Bl.
- Language
-
Englisch
- Notes
-
Ill., graph. Darst.
Text engl.
Jena, Univ., Diss., 2003 (Nicht für den Austausch)
- Keyword
-
Antisense-Oligonucleotide
Vasopressin
Genexpression
Tierversuch
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 11:41 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
In-vivo-antisense-Targeting von Vasopressin mRNA in Ratten : = In vivo antisense targeting on vasopressin mRNA in rats
Antisense RNA protects mRNA from RNase E degradation by RNA–RNA duplex formation during phage infection
An antisense noncoding RNA enhances translation via localized structural rearrangements of its cognate mRNA
Regulation of dendritic MAP2 mRNA targeting by MARTA2 in Rattus norvegicus
The role of the budding yeast RNA-binding proteins Khd1p and Loc1p in mRNA targeting
Quantifizierung nativer mRNA
Antisense oligonucleotide- and CRISPR-Cas9-mediated rescue of mRNA splicing for a deep intronic CLRN1 mutation
GIGYF recruits mRNA decay factors to repress target mRNA expression
![Antifibrotic therapy in the liver by adenovirus mediated expression of a TGF β1 [beta 1] antisense mRNA](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Antifibrotic therapy in the liver by adenovirus mediated expression of a TGF β1 [beta 1] antisense mRNA
AntisenseRNA mediated gene regulation via double stranded RNA formation
From antisense RNA to RNA modification: therapeutic potential of RNA-based technologies
On quantitative mRNA transfection
In-vivo-antisense-Targeting von Vasopressin mRNA in Ratten : = In vivo antisense targeting on vasopressin mRNA in rats
Antisense RNA protects mRNA from RNase E degradation by RNA–RNA duplex formation during phage infection
An antisense noncoding RNA enhances translation via localized structural rearrangements of its cognate mRNA
Regulation of dendritic MAP2 mRNA targeting by MARTA2 in Rattus norvegicus
The role of the budding yeast RNA-binding proteins Khd1p and Loc1p in mRNA targeting
Quantifizierung nativer mRNA
Antisense oligonucleotide- and CRISPR-Cas9-mediated rescue of mRNA splicing for a deep intronic CLRN1 mutation
GIGYF recruits mRNA decay factors to repress target mRNA expression
Antifibrotic therapy in the liver by adenovirus mediated expression of a TGF β1 [beta 1] antisense mRNA
AntisenseRNA mediated gene regulation via double stranded RNA formation
From antisense RNA to RNA modification: therapeutic potential of RNA-based technologies
On quantitative mRNA transfection
In-vivo-antisense-Targeting von Vasopressin mRNA in Ratten : = In vivo antisense targeting on vasopressin mRNA in rats
Antisense RNA protects mRNA from RNase E degradation by RNA–RNA duplex formation during phage infection
An antisense noncoding RNA enhances translation via localized structural rearrangements of its cognate mRNA
Regulation of dendritic MAP2 mRNA targeting by MARTA2 in Rattus norvegicus
The role of the budding yeast RNA-binding proteins Khd1p and Loc1p in mRNA targeting
Quantifizierung nativer mRNA
Antisense oligonucleotide- and CRISPR-Cas9-mediated rescue of mRNA splicing for a deep intronic CLRN1 mutation
GIGYF recruits mRNA decay factors to repress target mRNA expression
Antifibrotic therapy in the liver by adenovirus mediated expression of a TGF β1 [beta 1] antisense mRNA
AntisenseRNA mediated gene regulation via double stranded RNA formation
From antisense RNA to RNA modification: therapeutic potential of RNA-based technologies